Please use this identifier to cite or link to this item:
https://nslhd.intersearch.com.au/nslhdjspui/handle/1/38176
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Atukorala, I. | en |
dc.contributor.author | Pathmeswaran, A. | en |
dc.contributor.author | Chaturanga, Y. | en |
dc.contributor.author | Chang, T. | en |
dc.contributor.author | Zhang, Y. | en |
dc.contributor.author | Hunter, David J. | en |
dc.date.accessioned | 2022-05-13T21:37:50Z | - |
dc.date.available | 2022-05-13T21:37:50Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | 29:S230-S230 | en |
dc.identifier.uri | https://nslhd.intersearch.com.au/nslhdjspui/handle/1/38176 | - |
dc.description.abstract | Background: Ocrelizumab is an anti-CD20 monoclonal antibody that has been shown to reduce disability progression in primary progressive multiple sclerosis (MS). The adverse event profile is still being determined through postmarketing surveillance and case reports. Objective: To report a case of severe late-onset neutropenia associated with ocrelizumab in a patient with primary progressive MS. Methods: Case report. Result: A 34-year-old male with primary progressive MS developed severe late-onset neutropenia 42 days after infusion of ocrelizumab, which necessitated hospital admission and administration of broad-spectrum antibiotics and granulocyte colony-stimulating factor. Conclusion: Late-onset neutropenia is a rare complication of ocrelizumab. Patients should be counseled to present for urgent evaluation if they develop fever. | en |
dc.language.iso | en | en |
dc.relation.ispartof | Osteoarthritis & Cartilage | en |
dc.title | Is knee buckling, knee injury, squatting and kneeling associated with pain flares in knee osteoarthritis? | en |
dc.type | Article | en |
dc.identifier.affiliation | Royal North Shore Hospital | en |
dc.identifier.doi | http://dx.doi.org/10.1016/j.joca.2021.02.311 | - |
dc.description.pages | S230 | en |
dc.relation.url | https://www.sciencedirect.com/science/article/pii/S1063458421003484?via%3Dihub | en |
dc.subject.aht | Drug Therapy | en |
dc.subject.aht | Multiple Sclerosis | en |
local.editedby.name | JE 09082022 | en |
dc.relation.department | Rheumatology | en |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
crisitem.author.dept | Rheumatology | - |
crisitem.author.dept | Royal North Shore Hospital | - |
crisitem.author.dept | Rheumatology | - |
Appears in Collections: | Research Publications |
Items in NSLHD are protected by copyright, with all rights reserved, unless otherwise indicated.